Distinct substrate specificity and physicochemical characterization of native human hepatic thymidine phosphorylase.

作者: Taesung Oh , Mahmoud H. el Kouni

DOI: 10.1371/JOURNAL.PONE.0202826

关键词: ExtracellularPeptide sequenceBiochemistryAmino acidPyrimidine metabolismThymidineThymidine phosphorylaseEnzymeChemistryPhosphorolysis

摘要: Thymidine phosphorylase (TP; EC 2.4.2.4) is involved regulation of intra- or extracellular thymidine concentration, angiogenesis, cancer chemotherapy, radiotherapy, as well tumor imaging. Although the liver main site pyrimidine metabolism and contains high levels TP, nonetheless, purification characterization human hepatic TP has not been accomplished. We here report native TP. The enzyme was purified to apparent homogeneity by a procedure shorter more efficient than previously reported methods. Human an Kthymidine 285 ± 55 μM. Like from other tissues, it highly specific 2'-deoxyribosides. However, in contrast normal active phosphorolysis 5'-deoxy-5-fluorouridine, riboside 5-fluorouridine. Furthermore, exists different aggregates 50 kDa subunits, with unknown aggregation factor(s) while extra tissues homodimer. Isoelectric point determined 4.3. A total 65 residues N-terminal were sequenced. sequence these amino acids 100% location homology deduced acid platelet derived-endothelial cell growth factor (PD-ECGF) cDNA. contrary PD-ECGF, blocked. block neither N-formyl nor pyrrolidone carboxylic moieties. differences substrate specificities, existence multimers, weak interaction hydroxyapatite resin strongly suggest that distinct extrahepatic tissues. These results may have important clinical implications when activation deactivation chemotherapeutic agents

参考文章(47)
Yuko Tsukamoto, Yukio Kato, Masako Ura, Ikuo Horii, Hideo Ishitsuka, Hiroyuki Kusuhara, Yuichi Sugiyama, A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans : The mechanism for tumor-selective accumulation of 5-FU Pharmaceutical Research. ,vol. 18, pp. 1190- 1202 ,(2001) , 10.1023/A:1010939329562
Nicholas S. BROWN, Roy BICKNELL, THYMIDINE PHOSPHORYLASE, 2-DEOXY-D-RIBOSE AND ANGIOGENESIS Biochemical Journal. ,vol. 334, pp. 1- 8 ,(1998) , 10.1042/BJ3340001
T.-P. D. Fan, D.-E. Hu, C. R. Hiley, Development and Validation of a Sponge Model for Quantitative Studies on Angiogenesis Springer, Boston, MA. pp. 317- 332 ,(1992) , 10.1007/978-1-4615-3358-0_30
William D. Ensminger, Steven Come, Emil Frei, Glenn Steele, Michael Glode, Vic Raso, Andre Rosowsky, David C. Levin, A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Research. ,vol. 38, pp. 3784- 3792 ,(1978)
AKIRA KONO, YASUHIRO HARA, SETSURO SUGATA, YOSHIKAZU MATSUSHIMA, TOHRU UEDA, Substrate specificity of a thymidine phosphorylase in human liver tumor. Chemical & Pharmaceutical Bulletin. ,vol. 32, pp. 1919- 1921 ,(1984) , 10.1248/CPB.32.1919
Barbour S. Warren, Walter M. Williams, Frank P. LaCreta, Effects of Pyrimidine Nucleoside Phosphorylase Inhibitors on Hepatic Fluoropyrimidine Elimination in the Rat Cancer Research. ,vol. 49, pp. 2567- 2573 ,(1989)
Peter W. Woodman, Awni M. Sarrif, Charles Heidelberger, Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine. Cancer Research. ,vol. 40, pp. 507- 511 ,(1980)
Tomoyuki Sumizawa, Wierzba Konstanty, Shin-ichi Akiyama, Kazutaka Miyadera, Misako Haraguchi, Yuji Yamada, Hiroki Yoshida, Role of Thymidine Phosphorylase Activity in the Angiogenic Effect of Platelet-derived Endothelial Cell Growth Factor/Thymidine Phosphorylase Cancer Research. ,vol. 55, pp. 1687- 1690 ,(1995)
Mahmoud H. el Kouni, Mustapha M. el Kouni, Fardos N. M. Naguib, Differences in Activities and Substrate Specificity of Human and Murine Pyrimidine Nucleoside Phosphorylases: Implications for Chemotherapy with 5-Fluoropyrimidines Cancer Research. ,vol. 53, pp. 3687- 3693 ,(1993)